Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
5.04
-0.19 (-3.63%)
Jul 24, 2026, 1:57 PM EDT - Market open
Seres Therapeutics Employees
Seres Therapeutics had 66 employees as of December 31, 2025. The number of employees decreased by 37 or -35.92% compared to the previous year.
Employees
66
Change (1Y)
-37
Growth (1Y)
-35.92%
Revenue / Employee
$17,379
Profits / Employee
-$710,591
Market Cap
48.81M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 66 | -37 | -35.92% |
| Dec 31, 2024 | 103 | -130 | -55.79% |
| Dec 31, 2023 | 233 | -198 | -45.94% |
| Dec 31, 2022 | 431 | 98 | 29.43% |
| Dec 31, 2021 | 333 | 178 | 114.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Xilio Therapeutics | 76 |
| aTyr Pharma | 60 |
| Mereo BioPharma Group | 39 |
| INmune Bio | 21 |
| Edesa Biotech | 17 |
| Instil Bio | 17 |
| MiNK Therapeutics | 15 |
| Eloxx Pharmaceuticals | 10 |
MCRB News
- 16 days ago - Seres Therapeutics Transcript: Study result - Transcripts
- 16 days ago - Seres Therapeutics Press release: Study result - Filings
- 16 days ago - Seres Therapeutics Slides: Study result - Filings
- 16 days ago - Seres Therapeutics Transcript: AGM 2026 - Transcripts
- 16 days ago - Seres Therapeutics announces top-line results from SER-155 trial - TheFly
- 16 days ago - Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC), a Frequent Adverse Reaction That Forces Many Patients to Halt Cancer Treatment - GlobeNewsWire
- 4 weeks ago - Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres' SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis - GlobeNewsWire
- 4 weeks ago - Seres Therapeutics initiated with a Buy at H.C. Wainwright - TheFly